&nbsp;

iccu-thumbnail-OH-CancerPoster_INUIT.jpg

Mar 2022

Document

iccu-thumbnail-OH-CancerPoster_METIS.jpg

Mar 2022

Regimen

AC+PEMB

Cancer Type:

Breast

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2023

Regimen

ASCI

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

asciminib - For the treatment of Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase, according to clinical criteria

Drugs Used:

asciminib

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2023

Document

iccu-thumbnail-OH-fn-postcard.jpg

Apr 2022

Document

iccu-thumbnail-OH-fn-postcard-2.jpg

Apr 2022

Document

iccu-thumbnail-OH-inuit-postcard.jpg

Apr 2022

Document

iccu-thumbnail-OH-metis-postcard.jpg

Apr 2022

Drug

azaCITIDine (tablets)

Other Name(s): Onureg®

Quick Link(s): Drug Monograph, Patient Info Sheet

Aug 2023

Regimen

ATEZ

Cancer Type:

Lung,

Non-Small Cell

Intent: Adjuvant

Funding:

New Drug Funding Program

Atezolizumab - Adjuvant Treatment for Non-Small Cell Lung Cancer

Drugs Used:

atezolizumab

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2024

Regimen

AMIV

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

amivantamab (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Oct 2023

Regimen

ICE+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Curative

Drugs Used:

riTUXimab (PDRP prior authorization),

mesna,